Please turn JavaScript on

National Organization for Rare Disorders

follow.it gives you an easy way to subscribe to National Organization for Rare Disorders's news feed! Click on Follow below and we deliver the updates you want via email, phone or you can read them here on the website on your own news page.

You can also unsubscribe anytime painlessly. You can even combine feeds from National Organization for Rare Disorders with other site's feeds!

Title: National Organization for Rare Disorders | NORD

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.08 / day

Message History

Annual state report card highlights progress and persistent gaps in access to care for 30 million Americans

WASHINGTON, D.C., Feb. 9, 2026 — Access to care for Americans living with rare diseases still depends heavily on where they live, according to the National Organization for Rare Disorders (NORD®...


Read full story

Leaders across research, clinical care, industry, and patient advocacy convene to accelerate rare disease breakthroughs from discovery to real-world patient impact

Norwell, Ma., Feb. 5, 2026 — The National Organization for Rare Disorders (NORD®) today announced the agenda for its second annu...


Read full story
How ​All of Us Data​ Reveals Scientific Insights​

A recent genomic analysis published in PLOS Genetics illustrates how large, diverse population cohorts can generate rare disease insights that are often difficult to obtain ...


Read full story
Partnership focuses on delivering high-quality medical education to improve rare disease patient outcomes

BOSTON AND WASHINGTON, D.C., January 6, 2026 – Medlive and the National Organization for Rare Disorders® are proud to announce that NORD has again se...


Read full story

The Senate’s failure to advance the Give Kids a Chance Act through unanimous consent is deeply disappointing. 

For more than a year, thousands of rare disease advocates have engaged lawmakers across both parties to urge passage of the Give Kids a Chance Act, which includes reauthorization of the Rare Pediatric Disease Priority Review Voucher Program and passage of oth...


Read full story